Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Clinical and Translational Radiation Oncology|December 24, 2025
Daily adaptive MR-guided stereotactic ablative re-irradiation (re-SABR) in oligometastatic liver disease: A single-institution retrospective analysisElena Moreno-Olmedo, Dan Murray, Ben George, et al.
The Journal of Allergy and Clinical Immunology|February 8, 2020
Optimal identification of human conventional and nonconventional (CRTH2-IL7Rα-) ILC2s using additional surface markersSucai Liu, Kapil Sirohi, Mukesh Verma, et al.
The Journal of Allergy and Clinical Immunology|April 24, 2017
Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: The role of thymic stromal lymphopoietinSucai Liu, Mukesh Verma, Lidia Michalec, et al.
BJC Reports|September 2, 2024
Results and lessons learnt from the WISTERIA phase I trial combining AZD1775 with cisplatin pre- or post-operatively in head and neck cancerAnthony Kong, Amanda J Kirkham, Joshua S Savage, et al.
BMJ Open|September 14, 2023
Evaluation of hypofractionated adaptive radiotherapy using the MR Linac in localised pancreatic cancer: protocol summary of the Emerald-Pancreas phase 1/expansion study located at Oxford University Hospital, UKSuliana Teoh, Alexander Ooms, Ben George, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2005
Low-dose outpatient chemobiotherapy with temozolomide, granulocyte-macrophage colony stimulating factor, interferon-alpha2b, and recombinant interleukin-2 for the treatment of metastatic melanomaRobert W Weber, Steven O'Day, Madalene Rose, et al.
International Journal of Radiation Oncology, Biology, Physics|September 18, 2012
Targeted radiosensitization by the Chk1 inhibitor SAR-020106Gerben R Borst, Martin McLaughlin, Joan N Kyula, et al.
BMJ Open|March 19, 2020
Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: the WISTERIA trial protocolAnthony Kong, James Good, Amanda Kirkham, et al.
Advances in Radiation Oncology|November 10, 2025
Safety and Efficacy of Stereotactic Magnetic Resonance-Guided Adaptive Radiation Therapy (SMART) for Ultracentral Metastases in Non-Small Cell Lung CancerElena Moreno-Olmedo, Ben George, Kasia Owczarczyk, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 4, 2026
Intention to treat outcomes following management of locally advanced pancreatic ductal adenocarcinoma with curative intent: single centre cohort studyMoath Alarabiyat, Saad Rehman, Peter L Labib, et al.
Pageof 3